Riskpilot← Back to searchSign inGet full accessNEDRE GLOMMA DYREKLINIKK AS
ASActiveOrg 915846149Dikeveien 34, 1661 RolvsøyVeterinary activities · NACE 7500Est. 20156 employees
Revenue 2024
NOK 5,4M
0% vs 2023
EBITDA margin
1.7%
-68% vs 2023
Equity ratio
2.4%
Financial strength
Net profit 2024
NOK 56K
-70% vs 2023
| Revenue | NOK 5,4M | +0% |
| EBITDA | NOK 90K | -68% |
| Net profit | NOK 56K | -70% |
| Total assets | NOK 1,2M | -11% |
| Equity | NOK 29K | +207% |
| Employees | 6 | — |
Legal name
NEDRE GLOMMA DYREKLINIKK AS
Org number
915846149
Legal form
Aksjeselskap
NACE code
7500 · Veterinary activities
Founded
9. september 2015
Share capital
NOK 30 000
Employees
6 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Daglig leder alene.
Company purpose
Veterinære tjenester og utvikling, kjøp, salg og utleie av driftsmidler samt salg av dyreartikler og kursvirksomhet.
Address
Dikeveien 34, 1661 Rolvsøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 4 880 | 4 683 | 4 981 | 5 364 | 5 351 |
| Staff expenses | −2 280 | −2 226 | −2 233 | −2 396 | −2 456 |
| EBITDA | 299 | 165 | 348 | 277 | 90 |
| Depreciation & amort. | −43 | −33 | −2 | −5 | −8 |
| EBIT | 256 | 132 | 346 | 272 | 82 |
| Net financials | −14 | −22 | −130 | −36 | −3 |
| Profit before tax | 242 | 110 | 216 | 237 | 78 |
| Tax | 60 | 30 | 48 | 52 | 23 |
| Net profit | 182 | 80 | 168 | 184 | 56 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 344 | 1 341 | 1 208 | 1 333 | 1 183 |
| Equity | −460 | −380 | −211 | −27 | 29 |
| Long-term debt | 799 | 565 | 0 | 12 | 0 |
| Short-term debt | 1 005 | 1 155 | 1 419 | 1 348 | 1 154 |
| Total debt | 1 804 | 1 721 | 1 419 | 1 360 | 1 155 |
EBITDA margin
1.7%
This company
15.8%
Market median
-89% vs market
20202024
Equity ratio
2.4%
This company
38.2%
Market median
-94% vs market
20202024
Return on equity
193.2%
This company
18.4%
Market median
+950% vs market
20202024
Net profit margin
1.0%
This company
8.1%
Market median
-88% vs market
20202024
Asset turnover
4.52×
This company
1.12×
Market median
+304% vs market
20202024
Debt / equity
40.18×
This company
0.62×
Market median
-6381% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
IE Chief Executive Officer | Chief Executive Officer | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2018 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NEDRE GLOMMA DYREKLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ida Elise Berger Løvland | Chief Executive Officer | 0 companies |
| Tom-Martin Berger Løvland | Chairman | 0 companies |